News

Earlier, in March 2010, Novalar and Sanofi-Aventis signed a license and distribution agreement for OraVerse. The FDA approved OraVerse is indicated for reversal of the soft-tissue anesthesia and

NEB said that all the necessary enzymes and buffers for fast fragment library preparation are provided by these new products. Additionally, the Master Mix Set further streamlines the

PPI-461 is Presidio Pharma’s lead HCV NS5A inhibitor. The trial evaluated four single doses of PPI-461, followed by a five-day, once-a-day treatment regimen with PPI-461 at the highest

The acquisition is expected to expand P2i’s product portfolio beyond its technologies for liquid repellency, adding functional coating technologies with applications including anti-bacterial resistance, liquid attracting (super wettable),

Neptune has posted a net income of $476,000 for the Q1 ended May 31, 2010, compared to a net loss of $1,407,000 for the corresponding period ended May

Meridian Biosciencesaidthat the new illumigene C difficile molecular diagnostic system also provides high levels of sensitivity for diagnosing the serious, infectious disease. Its simple workflow requires minimal hands-on

NicVAX is Nabi’s proprietary investigational vaccine being developed to treat nicotine addiction and prevent smoking relapse. Nabi said that the patient enrollment in a second Phase III trial

Plumat said that BFL 854 offers control over safety issues as well as a reduction in product contamination risk during the fill/seal process. Plumat claimed that the new

Gilead Sciences’ lawsuit against Lupin is based on an abbreviated new drug application filed by Lupin, seeking approval to manufacture and market a generic version of Ranexa before